Colitis and Intestinal Inflammation in IL10−/− Mice Results From IL-13Rα2–Mediated Attenuation of IL-13 Activity

Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Gastroenterology (Impact Factor: 16.72). 10/2010; 140(1):254-64. DOI: 10.1053/j.gastro.2010.09.047
Source: PubMed

ABSTRACT The cytokine interleukin (IL)-10 is required to maintain immune homeostasis in the gastrointestinal tract. IL-10 null mice spontaneously develop colitis or are more susceptible to induction of colitis by infections, drugs, and autoimmune reactions. IL-13 regulates inflammatory conditions; its activity might be compromised by the IL-13 decoy receptor (IL-13Rα2).
We examined the roles of IL-13 and IL-13Rα2 in intestinal inflammation in mice. To study the function of IL-13Rα2, il10(-/-) mice were crossed with il13rα2(-/-) to generate il10(-/-)il13rα2(-/-) double knockout (dKO) mice. Colitis was induced with the gastrointestinal toxin piroxicam or Trichuris muris infection.
Induction of colitis by interferon (IFN)-γ or IL-17 in IL-10 null mice requires IL-13Rα2. Following exposure of il10(-/-) mice to piroxicam or infection with T muris, production of IL-13Rα2 increased, resulting in decreased IL-13 bioactivity and increased inflammation in response to IFN-γ or IL-17A. In contrast to il10(-/-) mice, dKO mice were resistant to piroxicam-induced colitis; they also developed less severe colitis during chronic infection with T muris infection. In both models, resistance to IFN-γ and IL-17-mediated intestinal inflammation was associated with increased IL-13 activity. Susceptibility to colitis was restored when the dKO mice were injected with monoclonal antibodies against IL-13, confirming its protective role.
Colitis and intestinal inflammation in IL10(-/-) mice results from IL-13Rα2-mediated attenuation of IL-13 activity. In the absence of IL-13Rα2, IL-13 suppresses proinflammatory Th1 and Th17 responses. Reagents that block the IL-13 decoy receptor IL-13Rα2 might be developed for inflammatory bowel disease associated with increased levels of IFN-γ and IL-17.

Download full-text


Available from: Satish Madala, Feb 10, 2014
47 Reads
  • Source
    • "Both receptors are present in conjunctival epithelium (Figure 1). A second IL-13 receptor, IL-13Rα2, exclusively binds IL-13 and has been found to serve as a decoy receptor (Wilson et al., 2011). We have previously found expression of the IL-13Rα1 in the conjunctival epithelium, with the strongest expression in goblet cell rich areas Figure 1 (de Paiva et al., 2010b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dry eye is an inflammatory disease that results from activation of innate inflammatory pathways in resident ocular surface cells, as well as cytokines produced by recruited T helper (Th) cells. Cytokines produced by the infiltrating Th cells alter the normal cytokine balance on the ocular surface and cause ocular surface epithelial pathology. Changes in levels of Th cytokines on the ocular surface have been measured in dry eye and the biological effects of these cytokines have been documented in experimental culture and mouse model systems. The Th2 cytokine IL-13 has a homeostatic role in promoting goblet cell differentiation. In contrast, The Th1 cytokine IFN-γ antagonizes IL-13 and promotes apoptosis and squamous metaplasia of the ocular surface epithelia. The Th17 cytokine, IL-17 promotes corneal epithelial barrier disruption. The ocular surface epithelium expresses receptors to all of these Th cytokines. Therapies that maintain normal IL-13 signaling, or suppress IFN- γ and IL-17 have potential for treating the ocular surface disease of dry eye.
    Experimental Eye Research 09/2013; 117. DOI:10.1016/j.exer.2013.08.013 · 2.71 Impact Factor
  • Source
    • "Taking the work of Schopf et al. further, the importance of IL-13 in the severe phenotype of the T. muris-infected IL-10-deficient mouse was explored. Thus Wilson et al. (2011) identified a critical role for the IL-13 decoy receptor (IL-13Ra2) in permitting the severe gut inflammation observed post T. muris infection, via its ability to attenuate IL-13 activity, enabling the heightened IFN-γ driven inflammation (Wilson et al. 2011). IL-27 has clear structural homology to IL-12, and, in common with this cytokine, is produced by APCs and is able to induce IFN-γ production from naïve T cells (Pflanz et al. 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: SUMMARYThe mouse whipworm Trichuris muris has long been used as a tractable model of human Trichuriasis. Here we look back at the history of T. muris research; from the definition of the species and determination of its life cycle, through to the complex immune responses that we study today. We highlight the key research papers that have developed our understanding of immune responses to this parasite, and reflect on how original concepts have been transformed, as our knowledge of immunology has grown. Although we have a good understanding of host–parasite interactions in the context of the underlying cellular immunology, there are still many aspects of the biology of the Trichuris parasite that remain undefined. We predict that advances in parasite biology will be key in the future development of new and improved treatments for Trichuriasis.
    Parasitology 09/2013; 140(11):1325-39. DOI:10.1017/S0031182013001054 · 2.56 Impact Factor
  • Source
    • "With respect to immunity to infection, we have previously reported that increased resistance to the helminth parasite Schistosoma mansoni following drug treatment and IL-10R blockade led to elevated antigen-specific IFNγ, IL-5 and IL-17A production [172]. Similarly, lethal infection of IL-10-deficient mice with the intestinal whipworm parasite Trichuris muris led to increased parasite-antigen-induced IFNγ and IL-17A [173]. Whether elevated T-cell-derived IFNγ and IL-17A secretions were from TH2 cells (i.e. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Following thymic output, αβ(+)CD4(+) T cells become activated in the periphery when they encounter peptide-major histocompatibility complex. A combination of cytokine and co-stimulatory signals instructs the differentiation of T cells into various lineages and subsequent expansion and contraction during an appropriate and protective immune response. Our understanding of the events leading to T-cell lineage commitment has been dominated by a single fate model describing the commitment of T cells to one of several helper (T(H)), follicular helper (T(FH)) or regulatory (T(REG)) phenotypes. Although a single lineage-committed and dedicated T cell may best execute a single function, the view of a single fate for T cells has recently been challenged. A relatively new paradigm in αβ(+)CD4(+) T-cell biology indicates that T cells are much more flexible than previously appreciated, with the ability to change between helper phenotypes, between helper and follicular helper, or, most extremely, between helper and regulatory functions. In this review, we comprehensively summarize the recent literature identifying when T(H) or T(REG) cell plasticity occurs, provide potential mechanisms of plasticity and ask if T-cell plasticity is beneficial or detrimental to immunity.
    Open Biology 01/2013; 3(1):120157. DOI:10.1098/rsob.120157 · 5.78 Impact Factor
Show more